Literature DB >> 6897124

Relapse rates after initial ulcer healing with sucralfate and cimetidine.

I N Marks, J P Wright, W Lucke, A H Girdwood.   

Abstract

The relapse rate after successful short-term therapy with sucralfate (Sc) or cimetidine (Cm) was studied in a group of 86 patients with recently healed duodenal or gastric ulcers. The patients were endoscoped on clinical relapse or, routinely, at 6 weeks, 6 months, and 1 year. Patients whose ulcers had healed with Cm relapsed earlier than did those whose ulcers had healed with Sc (p less than 0.05 at 12 weeks), but the cumulative relapse rate by the end of 1 year was of the order of 70% in both treatment groups. The mean duration of remission in patients who developed a recurrence was significantly greater in patients treated initially with Sc than in those treated initially with Cm--7.3 and 4.6 months, respectively (p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897124     DOI: 10.3109/00365528209182081

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Gastric cytoprotection. What does it really mean for the prescriber?

Authors:  M Guslandi
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

2.  Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

Authors:  J P Miller; E B Faragher
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

3.  Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.

Authors:  A L Blum; H Bethge; J C Bode; W Domschke; G Feurle; K Hackenberg; B Hammer; W Hüttemann; M Jung; G Kachel
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

4.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

Review 5.  Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials.

Authors:  G Dobrilla; P Vallaperta; S Amplatz
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

Review 6.  Long term treatment of duodenal ulcer. A review of management options.

Authors:  G Bianchi Porro; F Parente
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

7.  Ranitidine 150 mg at night in the prevention of gastric ulcer relapse.

Authors:  R Jorde; P G Burhol; T Hansen
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

8.  Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis.

Authors:  W M Hui; S K Lam; P Y Chau; J Ho; I Lui; C L Lai; A S Lok; M M Ng
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.